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During β-adrenergic stimulation of brown adipose tissue (BAT), p38 phosphorylates the
activating transcription factor 2 (ATF2) which then translocates to the nucleus to activate the
expression of Ucp1 and Pgc-1α. The mechanisms underlying ATF2 target activation are
unknown. Here we demonstrate that p62 (Sqstm1) binds to ATF2 to orchestrate activation of
the Ucp1 enhancer and Pgc-1α promoter. P62Δ69-251 mice show reduced expression of Ucp1
and Pgc-1α with impaired ATF2 genomic binding. Modulation of Ucp1 and Pgc-1α expression
through p62 regulation of ATF2 signaling is demonstrated in vitro and in vivo in p62Δ69-251
mice, global p62−/− and Ucp1-Cre p62flx/flx mice. BAT dysfunction resulting from p62
deficiency is manifest after birth and obesity subsequently develops despite normal food
intake, intestinal nutrient absorption and locomotor activity. In summary, our data identify
p62 as a master regulator of BAT function in that it controls the Ucp1 pathway through
regulation of ATF2 genomic binding.
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Having long been considered dispensable, brown adiposetissue (BAT) in adult humans is now recognized today asan organ of physiological relevance for energy metabo-
lism1–3. In adult humans, the mass and activity of BAT inversely
correlates with body mass index (BMI) and percent body fat4–6,
and sympathetic nervous system (SNS) activation by cold expo-
sure7–9, or by β3-adrenergic receptor agonism10 enhances BAT
thermogenesis and energy expenditure. The mitogen-activated
protein kinase (MAPK) p38α, the key regulator of adaptive ther-
mogenesis, modulates uncoupling protein 1 (Ucp1) and peroxi-
some proliferator-activated receptor gamma coactivator 1-alpha
(Pgc-1α) expression via phosphorylation, and action of the acti-
vating transcription factor 2 (ATF2)11,12. Upon activation by
p38α, p-ATF2 translocates to the nucleus and initiates expression
of Ucp1 and Ppargc1a (Pgc-1α) via binding to cAMP responsive
elements (CRE) in the Ucp1 enhancer and Pgc-1α promoter11.
Highlighting the key role of this pathway in UCP1 action, cold-
induced β-adrenergic receptor stimulation fails to promote Ucp1
expression in mouse BAT primary cells pretreated with the p38α/β
MAPK inhibitor SB20219012. While nuclear entry and action of
ATF2 is crucial for BAT adaptive thermogenesis11,12, the
mechanism underlying ATF2 target activation is unknown13.
Scaffold proteins are key mediators of selective and efficient cell
signal transduction, which they achieve through direct and specific
interaction with their target proteins. The scaffold protein p62
(sequestosome 1; Sqstm1) is a multimodular adaptor protein
involved in key metabolic processes like tissue inflammation, cell
differentiation, cell growth, and tumorigenesis14. Mice with global15
or adipose-specific16 deletion of p62 have a severe obese phenotype
with normal food intake but decreased energy expenditure and
impaired BAT function. Global p62−/− mice also have enhanced
adipogenesis with hyperphosphorylation of the extracellular signal-
regulated kinase (ERK1/2) in the white adipose tissue (WAT)15.
Loss of adipogenic capacity by ERK1/2 deletion can prevent obesity
in global p62−/− mice17, emphasizing uncertainty as to whether the
dysregulated energy metabolism in p62-deficient mice originates
from enhanced adipogenesis and/or impaired energy expenditure16.
The aim of this paper was to dissect the molecular foundations
underlying energy metabolism control by p62 and to identify the
molecular mechanisms of how p62 regulates BAT thermogenesis.
Our data demonstrate that mice that lack the amino acids (aa)
69–251 of the p62 protein (p62Δ69-251 mice) have normal protein
levels of p-ERK1/2 in WAT and show no changes in adipogenesis
or adipocyte differentiation. However, these mice develop a severe
obese phenotype that is accompanied by impaired energy expen-
diture and dysfunctional BAT. In a series of in vitro and
in vivo experiments using p62Δ69-251 mice, global p62-deficient mice
(p62−/−) and Ucp1-Cre p62flx/flx mice, we demonstrate that p62 is a
key signaling node of the UCP1 pathway. p62 directly binds to
ATF2 to orchestrate its genomic binding to and activation of the
Ucp1 enhancer and Pgc-1α promoter. As demonstrated in p62Δ69-
251 mice, global p62−/− mice and Ucp1-Cre p62flx/flx mice, lack of
p62 action leads to failure of ATF2 to activate its nuclear targets
Ucp1 and Pgc1α and results in impaired BAT function and
increased body weight. The cell autonomous effect of p62 to
modulate ATF2 nuclear target activation is confirmed in BAT pri-
mary cells from p62Δ69-251 mice and is verified in cultured BAT cells
of global p62−/− mice and Ucp1-Cre p62flx/flx mice. Our data
establish p62 as a key regulator of adaptive thermogenesis in that it
regulates the UCP1 pathway via modulation of ATF2 genomic
target activation.
Results
Generation of p62Δ69-251 mice. To dissect the role of p62 in
regulating systems metabolism, we generated mice in which the
amino acids 69–251 of the p62 protein have been deleted (p62Δ69-
251 mice). Mice were bred on the C57BL/6J background and were
designed to yield a truncated p62 protein of ∼37 kDa that lacks
the zinc finger (zz) domain, the TB1 domain and one of the two
p38 interacting motifs, but to otherwise maintain regular p62
function (Supplementary Fig. 1a). Consistent with this, we see no
difference in protein levels of phosphorylated protein kinase C (p-
PKC) in the liver (Supplementary Fig. 1b) and of p-ERK1/2 in
WAT of p62Δ69-251 mice (Supplementary Fig. 1c, d). Also, hepatic
protein levels of microtubule-associated protein 1 light chain 3
(LC3) are, as expected, unchanged in p62Δ69-251 mice (Supple-
mentary Fig. 1e), which is consistent with demonstration of
preserved p62 binding to LC3 and to p38 using immunopreci-
pitation analysis in HEK293FT cells (Supplementary Fig. 1f).
Notably, preserved p62 binding to p38 is not unexpected given
that only one of the two p38 binding motifs is deleted in
the p62Δ69-251 mice (Supplementary Fig. 1a) and no difference
in p38/p-p38 is observed in BAT of p62Δ69-251 mice and global
p62−/− mice (Supplementary Fig. 1g). We further see, as expec-
ted, no difference in autophagy, as assessed by hepatic protein
level of ATG7 (Supplementary Fig. 1h), or the proteasome
activity in BAT of p62Δ69-251 mice (Supplementary Fig. 1i).
Collectively, these data indicate that the p62 motifs not affected
by the p62Δ69-251 mutation remain functional.
p62Δ69-251 mice are obese with no difference in adipogenesis.
p62Δ69-251 mice develop an obese phenotype of identical
dimension relative to global and adipose-specific p62−/− mice
when fed with either regular chow or a high-fat diet (HFD)
(Fig. 1a, Supplementary Fig. 2). Since p-ERK1/2 is not changed in
WAT of either 12- or 32-wk-old p62Δ69-251 mice (Supplementary
Fig. 1c, d), ERK1/2 mediated adipogenesis can thus not explain
the obese phenotype of the p62Δ69-251 mice. Consistent with this,
we see adipocyte size and volume increased but the total number
of adipocytes decreased in the iWAT, eWAT, and rpWAT of
young 14-wk-old non-obese p62Δ69-251 mice (Supplementary
Fig. 3a-d). In none of the analyzed white fat depots (Supple-
mentary Fig. 4), nor in iWAT or BAT primary cells of p62Δ69-251
mice (Supplementary Fig. 5c-f, i-l), do we see major expression
differences indicative of enhanced adipogenesis or adipocyte
differentiation (Pparg, Fasn, Fabp4, Adipoq). This is further
supported by unaltered Oil Red O staining during differentiation
of BAT and iWAT primary cells (Supplementary Fig. 5a,b,g,h).
These data collectively show that obesity in p62Δ69-251 mice does
not result from changes in adipogenesis.
Obesity in chow-fed p62Δ69-251 mice (Fig. 1a) is primarily the
result of increased body fat with only a slight (but significant)
increase in lean tissue mass (Fig. 1b), and is accompanied by
glucose intolerance (Fig. 1c), elevated fasting levels of insulin
(Fig. 1d) and insulin resistance (Fig. 1e). The increased adiposity
is not related to changes in body length (Fig. 1f) or to circulating
levels of growth hormone (Fig. 1g), nor to alterations in food
intake (Fig. 1h) or the amount of nutrients that are made
available for metabolism (Fig. 1i, j). Since intake and absorption
of nutrients is unchanged in the p62Δ69-251 mice, these data
suggest that obesity in p62Δ69-251 mice results from alterations in
energy expenditure.
Obese p62Δ69-251 mice have an impaired BAT function. Upon
ANCOVA correction for body weight18, obese p62Δ69-251 mice
have strikingly decreased energy expenditure (Fig. 2a). Further-
more, p62Δ69-251 mice are cold intolerant and fail to appro-
priately increase their energy expenditure with decreasing
environmental temperature (Fig. 2b). While locomotor activity is
not different at either 30 or 23 °C, p62Δ69-251 mice increase their
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dark phase activity when exposed to either 10 or 5 °C (Fig. 2c).
Consistent with failure of the obese p62Δ69-251 mice to increase
their energy expenditure when exposed to cold (Fig. 2b), we see a
blunted increase in energy expenditure when p62Δ69-251 mice are
treated with norepinephrine (NE) (Fig. 2d). These data suggest
that the impaired energy expenditure of p62Δ69-251 mice resides
from inadequate activation of the BAT and that the p62Δ69-251
mice increase their locomotor activity upon cold exposure to
compensate for BAT dysfunction. Consistent with this, BAT
glucose uptake, measured by positron emission tomography/
magnetic resonance imaging (PET/MRI) following administra-
tion of 18F-FDG, is reduced in p62Δ69-251 mice (Fig. 2e) despite
normal activity of cytochrome c oxidase (COX) and thus func-
tional mitochondrial complex IV (Fig. 2f). The impaired BAT
function of p62Δ69-251 mice is associated with decreased expres-
sion of the key thermogenic genes Ucp1, Pgc-1α, diodinase 2
(Dio2), and cell death-inducing DNA fragmentation factor alpha
subunit-like effector A (Cidea) in BAT (Fig. 2g). Expression levels
Pgc-1α also decreased in iWAT of obese p62Δ69-251 mice with
very low to borderline expression of Ucp1 in both groups
(Fig. 2h). Notably, despite ~50% decreased expression of Ucp1
and ~80% decreased expression of Pgc-1α in the BAT (Fig. 2g),
we see protein levels of the upstream Ucp1 and Pgc-1α key acti-
vator p-ATF2 (Thr69/71) increased in BAT of obese p62Δ69-251
mice, with unchanged levels of p38 and p-p38 (Fig. 2i). Since p-
ATF2 induces expression of Ucp1 and Pgc-1α via direct binding to
CRE elements in the promoter/enhancer regions of these genes11,
these data suggest that p-ATF2 requires a critical p62 motif either
for nuclear translocation, or for binding and activating the CRE
elements of the Ucp1 enhancer and Pgc-1α promoter.
Impaired BAT function in young non-obese p62Δ69-251 mice. If
p62 is required for adequate BAT function, then lack of
p62 signaling should already affect BAT thermogenesis before the
onset of obesity. In line with this notion, we see BAT temperature
























































































































































































































































Fig. 1 Metabolic phenotype of chow-fed male p62Δ69-251 mice. Body weight development (a) as well as body composition (b) and glucose tolerance (c) in
31-wk-old male C57Bl/6J wt or p62Δ69-251 mice. Fasted insulin levels (d) and insulin sensitivity (e) in 24-wk-old male mice. Body length at the age of 14,
16, or 20 wks (f). Growth hormone at the age of 14 wks (g). Cumulative food intake (h) as well as assimilated energy (i) and assimilation efficiency (j) at
the age of 30 wks. Sample sizes are (a–c) n= 9/7 mice, (d, e) n= 7/8 mice, (f) n= 7/7 mice, n= 8/8 mice, n= 8/8 mice, (g) n= 7/7 mice. Cumulative
food intake (h) was assessed per cage in n= 6/4 cages containing n= 9/7 mice. For panels (i) and (j), feces were collected per cage in n= 4/4 cages
containing n= 8/8 mice. Data represent mean ± SEM. Longitudinal data in panels (a), (c), (e), and (h) were analyzed using two-way ANOVA with time
and genotype as co-variant and using Bonferroni post hoc multiple comparison analysis for differences at individual time points. Bar graphs in panels (b),
(c), (d), (f), (g), (i), and (j) were analyzed using two-sided two-tailed t-test. *p < 0.05; **p < 0.01; ***p < 0.001. Exact p-values are (a) d17 p= 0.0318, d18
p= 0.0125, d19 p < 0.0001, d20 p= 0.0002, d21–d30 p < 0.0001; (b) p= 0.000001996 and p= 0.0228; (c) 30min p < 0.0001, 60min p= 0.0004; AUC
p= 0.00467; (d) p= 0.0132; (e) 60min p= 0.0237, 120min p= 0.0358. AUC area under curve, Eass assimilated energy.
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p62Δ69-251 pups relative to wt controls, as assessed by infrared
thermography (Fig. 3a). Consistent with this, in 12-wk-old non-
obese p62Δ69-251 mice we see, despite yet unchanged body weight
(Fig. 3b), energy expenditure already decreased (Fig. 3c). Similar
to the obese p62Δ69-251 mice, locomotor activity is unchanged
under room temperature also in the young non-obese p62Δ69-251
mice (Fig. 3d), but expression of key thermogenic genes Ucp1,
Pgc-1α, PR/SET domain 16 (Prdm16), Dio2, and Cidea are
decreased in BAT (Fig. 3e). These data imply that the abrogated
BAT function is a direct result of p62 deficiency and is not a
consequence of the obese phenotype. Consistent with this, gene
signatures indicative of decreased thermogenesis (Ucp1, Pgc-1α,
Prdm16) are confirmed also in BAT and iWAT primary cells
harvested from young non-obese p62Δ69-251 mice (Supplemen-
tary Fig. 6a-h).
In line with the notion that young non-obese p62Δ69-251 mice
already have an energy surplus due to decreased energy
expenditure (Fig. 3c), we see histological differences in the
adipose tissue even before their body weight separates from the
wt controls. Accordingly, at the age of 14 wks, the p62Δ69-251 mice
show enhanced lipid accumulation in BAT, iWAT, eWAT, and
rpWAT with greater abundance of large adipocytes in all
analyzed fat depots (Supplementary Fig. 3a-d) and increased
weight of the iWAT and eWAT but not yet of the BAT and
rpWAT (Supplementary Fig. 7a-g). Also levels of triglycerides but
not cholesterol are already increased in the liver of these young
non-obese p62Δ69-251 mice (Supplementary Fig. 7h,i).
Impaired BAT function in Ucp1-Cre p62flx/flx mice. To corro-












































































































































































































































































Fig. 2 Impaired energy expenditure and BAT thermogenesis in obese p62Δ69-251 mice. Energy expenditure (EE) plotted against body weight and
ANCOVA predicted energy expenditure at a given body weight of 40 g in obese 32-wk-old male C57Bl/6J wt or p62Δ69-251 mice fed a regular chow diet.
When considering body weight as covariate, the ANCOVA genotype effect is p= 0.016 (a). Predicted energy expenditure (b) and locomotor activity
during the dark phase (c) of 26-wk-old male mice at different environmental temperatures. Energy expenditure of male mice during a norepinephrine (NE)
challenge at 30 °C (d). PET/MRI imaging of male 8-mths-old male mice with standardized uptake values (SUV); white arrow indicates location of BAT (e).
Cytochrome c oxidase (COX) activity normalized to protein concentration (f), thermogenic gene expression profiling in BAT (g) and iWAT (h), and protein
levels of p-p38, p38, ATF2, p-ATF2 (Thr69/71), and GAPDH (i) in BAT of obese 33-wk-old male mice. Samples sizes are (a) n= 8/7 mice, (b, c) n= 8/6
mice, (d) n= 8/8 mice, (e) n= 5/7 mice, (f) n= 7/7 mice, (g) Ucp1 n= 8/7 mice; Pgc-1α n= 7/7 mice, Prdm16 n= 8/7 mice, Dio2 n= 7/6 mice, Cidea
n= 8/7 mice, (h) Ucp1 n= 8/6 mice, Pgc-1α n= 8/7 mice, Prdm16 n= 8/7 mice, Cidea n= 8/7 mice, (i) representative western blot of n= 4 (out of n= 6)
p62 wt and n= 4 (out of n= 6) p62Δ69-251 mice and quantification of pATF2/GAPDH in n= 6 mice each genotype. The full blot with n= 6 mice each
genotype is provided in the Source data file. Data represent mean ± SEM. Data in panels (a) and (b) were analyzed using ANCOVA using body weight as
covariate. Bar graphs in panels (a), (b), (c), (e), (f), (g), (h), and (i) were analyzed using two-side two-tailed t-test. Data in (d) were analyzed using two-
way ANOVA using time and genotype as covariates and with Bonferroni post hoc multiple comparison test for each individual time-point. *p < 0.05; **p <
0.01; ***p < 0.001. Exact p-values are given in the Source data file. Hprt hypoxanthine guanine phosphoribosyltransferase, Prdm16 PR/SET domain 16,
Cidea cell death-inducing DNA fragmentation factor alpha subunit-like effector A, Dio2 deiodinase 2, GAPDH Glyceraldehyde-3-phosphate
dehydrogenase.
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generated mice with targeted deletion of p62 specifically in the
BAT (Ucp1-Cre p62flx/flx). In BAT of these mice, expression of
p62 is decreased by ~75% relative to wt controls (Fig. 4a). Despite
showing 25% residual expression of p62 in BAT, these Ucp1-Cre
p62flx/flx mice show decreased BAT surface temperature after
birth (Fig. 4b, c) and show a greater body weight gain relative to
wt controls (Fig. 4d, e). Notably, while mice with global p62
deletion15, WAT/BAT-specific p62 deletion16, global p62Δ69-251
mutation (Fig. 2a, Supplementary Fig. 2a,d), and BAT-specific
p62 deletion (Fig. 4) all become obese with impaired BAT func-
tion, mice with CNS-specific p62 deletion do not become obese16.
These data collectively demonstrate that the metabolic dysfunc-
tion residing in p62 deficiency originates from p62 signaling in
the BAT and is independent of p62 signaling in the CNS. Con-
sistent with the p62Δ69-251 mice, also the increased body weight of
the Ucp1-Cre p62flx/flx mice is not accompanied by changes in
food intake (Fig. 4f), but expression of key thermogenic genes
(Ucp1, Pgc-1α, Cidea) are decreased in in vitro cultured brown
adipocytes of the Ucp1-Cre p62flx/flx mice (Fig. 4g–i). In line with
these data, isoproterenol fails to induce Ucp1 mRNA levels in
BAT primary cells of the Ucp1-Cre p62flx/flx mice (Fig. 4j).
p62 regulation of BAT function is cell autonomous. We also
assessed energy expenditure using Seahorse analysis and see basal
respiration and proton leak respiration decreased in BAT primary
cells of p62Δ69-251 mice (Fig. 5a, b). In agreement with our obser-
vation that p-ATF2 is increased and expression of Ucp1 decreased in
the p62Δ69-251 mice (Fig. 2g, i), we see increased levels of p-ATF2,
yet lower protein and transcript levels of Ucp1 also in BAT primary
cells of p62Δ69-251 mice; even when cells are stimulated with
isoproterenol (Fig. 5c, d). These in vitro data again suggest that p-
ATF2 requires functional p62 to access or activate the CRE elements
in the promoter/enhancer region of Ucp1 and Pgc-1α, and they
consequently further demonstrate that the effects of p62 on BAT
function are cell autonomous and are not driven by CNS effects.
p62 regulates ATF2 nuclear target activation. We next tested
whether p62 is a direct ATF2 interaction partner and whether p62
is required either for ATF2 nuclear translocation or for binding to
and activation of its nuclear targets. Immunoprecipitation ana-
lysis in HEK293T cells showed direct binding of p62 to ATF2
(Fig. 6a) without ability of p62 to directly activate (phosphorylate)
ATF2 (Fig. 6b). Notably, p62 binding to ATF2 is observed under
both baseline conditions and after stimulation with isoproterenol
and is preserved even in the p62Δ69-251 mutants (Fig. 6a). We
next tested whether p62 is required for nuclear translocation of
ATF2 and quantified the cytosolic and nuclear content of ATF2.
In line with the observation that p62 binding to ATF2 is pre-
served in p62Δ69-251 mutant cells (Fig. 6a), nuclear presence of p-
ATF2 is preserved in BAT of the p62Δ69-251 mice under both
baseline conditions and after β-adrenergic receptor stimulation
(Fig. 6c). Yet, despite normal activation (phosphorylation) and
nuclear presence of ATF2 in response to β-adrenergic receptor
stimulation, p-ATF2 fails to increase protein levels of UCP1 in
the p62Δ69-251 mice (Fig. 6c, d). Preservation of p-ATF2 nuclear
entry with failure to induce UCP1 levels are confirmed also in
BAT primary cells of Ucp1-Cre p62flx/flx mice (Fig. 6e) and in
BAT cells of global p62−/− mice (Fig. 6f). Consistent with the
observation that protein level of p38 and p-p38 are unchanged in



























































































































Fig. 3 Impaired energy expenditure and BAT thermogenesis in lean p62Δ69-251 mice. Infrared thermographic imaging and surface temperature of 7-d-old
male wt or p62Δ69-251 mice (a). Body weight (b), energy expenditure (c), and locomotor activity (d) of lean, non-obese 12-wk-old male mice fed with a
regular chow diet. Gene expression of thermogenic markers in BAT of lean non-obese 12-wk-old male mice (e). Sample sizes are (a) n= 6/6 mice, (b–d)
n= 8/8 mice, (e) Ucp1 n= 8/6 mice, Pgc-1α n= 8/7 mice, Prdm16 n= 8/7 mice, Dio2 n= 8/6 mice, Cidea n= 8/7 mice. Data represent mean ± SEM. Bar
graphs were analyzed using two-sided two-tailed t-test. *p < 0.05; **p < 0.01; ***p < 0.001. Exact p-values are (a) p= 0.000037; (b) p= 0.327; (c) mean
light p= 0.0425, mean dark p= 0.00128, mean total p= 0.0068; (d) mean light p= 0.691 mean dark p= 0.135, mean total p= 0.352; (e) Ucp1 p=
0.000383, Pgc1a p= 000217, Prdm16 p= 0.00064, Dio2 p= 0.0141, Cidea p= 0.00029.
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mice (Fig. 2i and Supplementary Fig. 1g), we see levels of p38 and
p-p38 also unchanged in the nuclear/cytosolic fractions of BAT in
young non-obese p62Δ69-251 mice (Fig. 6d) and this is confirmed
also in cultured BAT cells of the global p62−/− mice (Fig. 6f).
Collectively, these data indicate that the observed changes in p-
ATF2 are not related to changes in p38 and further suggest that
functional p62 is required for ATF2 to bind and activate its
nuclear targets. We next performed chromatin immunoprecipi-
tation (ChIP) assays in BAT of the p62Δ69-251 mice. There was
abundant endogenous genomic binding of ATF2 at canonical
target sites in BAT from wt mice (Fig. 7a). These ATF2 target
sites include promoters of Jun, Fos, and Atf319, as well as pre-
viously described BAT-specific ATF2 target sites within the Ucp1
enhancer (CRE2) and promoter (CRE4), and the Pgc-1α pro-
moter11. Importantly, ATF2 binding to target loci was severely
impaired in BAT from p62Δ69-251 mice (Fig. 7a) and this was
confirmed also in BAT from global p62−/− mice (Fig. 7b). These
data demonstrate that failure of ATF2 to induce Ucp1 and Pgc-1α
expression in the p62 mutant mice is associated with impaired
genomic binding of ATF2 to the promoter/enhancer regions of
target genes, and implies that functional p62 is required
for ATF2-mediated transcriptional activation. Consistent with
a previously described transcriptional co-regulator role for
p6220–22, we observed also reduced chromatin binding of p62 to
the promoter/enhancer regions of Ucp1 and Pgc-1α in BAT of the
p62−/− mice, and this was also confirmed in the BAT-specific
p62 ko mice (Supplementary Fig. 8a,b). To further validate this
finding, we assessed ATF2 target activation in vitro using a
luciferase-based CRE reporter assay. We co-transfected
HEK293T cells with an ATF2 sensor (pCRE-luc), along with
the dominant positive p38/ATF2 activator MKK6(K82A) and the
respective wt p62 or mutant p62Δ69-251. Consistent with our
finding that lack of p62 leads to impaired binding of ATF2 to
target genes (Fig. 7a, b), there was reduced transcriptional acti-
vation in cells transfected with the p62Δ69-251 plasmids relative to
the p62 wt controls (Fig. 7c). Collectively, these data demonstrate
that a motif encoded by the p62 amino acids 69–251 is required
for ATF2 to bind and activate its nuclear targets, and suggests
that its absence in the p62Δ69-251 mice leads to impaired energy
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Fig. 4 Impaired BAT function in p62flx/flx Ucp1-Cre mice. Expression of p62 in BAT of p62flx/flx Ucp1-Cre negative (Cre−) or p62flx/flx Ucp1-Cre positive
(Cre+) mice (a), infrared thermographic imaging in female and male mice (b) and surface temperature (c) of 7-d-old p62flx/flx Ucp1-Cre− or p62flx/flx Ucp1-
Cre+ mice. Body weight (d), body weight change (e), and cumulative food intake (f) of HFD-fed p62flx/flx male Ucp1-Cre− or p62flx/flx Ucp1-Cre+ mice.
Gene expression of Ucp1 (g), Pgc-1α (h) and Cidea (i) and isoproterenol-induction of Ucp1 mRNA expression (j) in BAT primary cells harvested from 6- to 8-
wk-old male p62flx/flx Ucp1-Cre− or p62flx/flx Ucp1-Cre+ mice, during 6 d of differentiation. Sample sizes are (a) n= 6/8 mice, (b) n= 3/5 mice, (c–e) n=
7/8 mice. f cumulative food intake was assessed per cage in n= 4/4 cages containing n= 7/8 mice; 2 cages (n= 1/1) were excluded because mice
shredded food. g–i BAT primary cells were harvested from p62 wt or Ucp1-cre p62flx/flx mice, plated with equal number of cells in n= 3 wells each genotype
and individually differentiated into mature brown adipocytes. Target gene expression was then measured in n= 3 individually differentiated wells each
genotype with two technical replicates each well. j BAT primary cells were harvested from p62 wt or Ucp1-cre p62flx/flx mice, plated with equal number of
cells in n= 3 wells each treatment group and individually differentiated into mature brown adipocytes. Target gene expression was then measured in n= 3
individually differentiated wells each treatment group with two technical replicates each well. Data in (d–i) are analyzed using two-way ANOVA using time
and genotype as covariate and using Bonferroni post hoc multiple comparison to test for differences in individual time points. Data in (a), (c), and (j) were
analyzed using two-sided two-tailed t-test. Data represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001; ****P < 0.0001. Exact p-values are (a) p=
0.000424; (c) p= 0.0428; (d) d23 p= 0.0286, d24 p= 0.0082, d25 p= 0.0070, d26 p= 0.150; (e) d22 p= 0.0019, d23 p= 0.0006, d24 p= 0.0004,
d25 p= 0.0009; (g) d4 p < 0.0001, d6 p < 0.0001; (h) d4 p= 0.0011, d6 p= 0.037; (i) d4 p= 0.0015, d6 p < 0.00; (j) p= 0.0116.
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activate key thermogenic targets in the nucleus, including the
promoter/enhancer regions of Ucp1 and Pgc-1α. Notably, while
BAT function is severely impaired in all three analyzed p62
mutant mouse models, no ATF2-mediated transcriptional chan-
ges are observed on stress and DNA damage, ER stress, inflam-
mation, cell cycle, cell death, and autophagy in either liver,
muscle, kidney, and spleen of p62Δ69-251 mice (Supplementary
Figs. 9,10).
Discussion
We here demonstrate that the scaffold protein p62 is a key reg-
ulator of the UCP1 pathway. Our data demonstrate that p62
regulates the UCP1 pathway in a cell autonomous manner by
directly binding to ATF2 and by regulating its binding to
the Ucp1 enhancer and Pgc-1α promoter. As demonstrated in
p62Δ69-251 mice, global p62−/− mice and Ucp-Cre p62flx/flx mice,
lack of p62 action results in severely impaired BAT function. We
attribute this to failure of ATF2 to bind and activate the pro-
moters/enhancers of its downstream thermogenic targets Ucp1
and Pgc-1α. These data are consistent with the observation that
lack of p62 in adipocytes, but not in the liver, muscle, myeloid
lineage cells or the CNS, results in impaired BAT function and an
obese phenotype16. A recent report suggested that the obese
phenotype of p62 deficiency originates from the lack of p62
action in the CNS, leading to hyperphagia and leptin resistance23.
However, while changes in energy expenditure are consistently
observed in mice lacking p62 either globally15 or in an adipose-
specific manner16, no major difference in food intake has been
observed in any of these mice. Consistent with this, we also report
here that p62Δ69-251 mice have impaired energy expenditure but
no difference in food intake. Moreover, also CNS-specific p62−/−
mice have no obese phenotype and normal food intake16. Also, as
occurs in the adipocyte-specific p62−/− mice, the impaired energy
expenditure of p62Δ69-251 mice cannot be explained by changes in
locomotor activity. Since BAT thermogenesis is the only observed
dysfunctional component of the energy balance equation, we
consequently conclude that impaired energy expenditure of BAT
is the causal factor leading to increased body weight in the p62-
deficient mice.
We also assessed whether p62Δ69-251 mice have ATF2 medi-
ated disturbances in other metabolic processes, like stress and
DNA damage, ER stress, inflammation, cell cycle, cell death, and
autophagy. None of these pathways seem overtly changed in
either liver, muscle, kidney, and spleen of p62Δ69-251 mice.











































































































































































Pgc-1αIso 0.5 μM Iso 0.5 μM
wt
40 50 60 70
Fig. 5 Cell autonomous regulation of energy expenditure by p62. Oxygen consumption rate (a), as well as basal and proton leak respiration (b) in BAT
primary cells harvested from 6- to 8-wk-old male wt or p62Δ69-251 mice. Western blot analysis of p-ATF2 (Thr69/71) and UCP1 (c) and gene expression of
Ucp1 and Pgc-1α (d) in 6 d differentiated BAT primary cells harvested from 6- to 8-wk-old male wt or p62Δ69-251 mice and which have been stimulated with
saline (vhcl) or isoproterenol (0.5 μM) for 6 h. For measurement of oxygen consumption (a), basal respiration (b) and proton leak respiration (c), BAT
primary cells were harvested from p62 wt or p62Δ69-251 mice, plated with equal number of cells in n= 4/5 wells each genotype and individually
differentiated into mature brown adipocytes. Oxygen consumption was then measured in n= 4/5 individually differentiated wells each genotype with n= 3
technical replicates each well. For data in panel (c), BAT primary cells were harvested from p62 wt or p62Δ69-251 mice, plated with equal number of cells in
n= 3 wells each treatment group and individually differentiated into mature brown adipocytes. Protein level of p-ATF2, GAPDH and UCP1 was then
measured in n= 3/3/3/3 individually differentiated wells. For data in panel (d), BAT primary cells were harvested from p62 wt or p62Δ69-251 mice, plated
with equal number of cells in n= 3 wells each treatment group and individually differentiated into mature brown adipocytes. Target gene expression was
then measured in n= 3/3/3/3 individually differentiated wells with n= 2 technical replicates each well. Panels (a) and (d) are representative examples of
two independently performed studies, each yielding similar results. Data in panel (a) have been analyzed using two-way ANOVA with time and genotype
as co-variant and using Bonferroni post hoc multiple comparison to test for differences in individual time points. Bar graphs have been analyzed using two-
sided two-tailed t-test. Data represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. Exact p-values are given in the Source data file.
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becomes most apparent when the mice are exposed to cold; when
the BAT is most active. In light of this notion, it seems possible
that other ATF2 signaling events only become apparent in the
p62 mutant mice after specific stimuli. In summary, we demon-
strate that the scaffold protein p62 is an essential key regulator of
adaptive thermogenesis and BAT function in that it regulates
Ucp1 and Pgc-1α via modulation of ATF2 genomic binding. On
an important note, the frequently observed increase in p-ATF2 in
BAT of the p62 mutant mice does not seem to be an integral part
of the pathological mechanism leading to the impaired BAT
function. Accordingly, while we consistently see across all three
analyzed p62 mutant mouse lines that p-ATF2 fails to activate its
nuclear targets Ucp1 and Pgc-1α (Fig. 6c, e, f), we see that levels of
p-ATF2 are often (Figs. 2i, 5c, and 6e, f) but not always (Fig. 6c)
increased in BAT. In summary, our data establish p62 as an
important regulator of the UCP1 pathway. Additional studies are
warranted to further characterize nuclear/cytosolic localization of
p62, and to determine whether p62 regulates BAT function also
via UCP1-independent mechanisms.
Methods
Animal studies. Mice were kept at a constant environment with ambient tem-
perature set to 22 ± 2 °C with constant humidity (45–65%) and a 12 h/12 h light/
dark cycle. Mice had free access to water and were fed ad libitum with either a
standard chow (Type 1314, Altromin GmbH, Lage, Germany) or HFD (58% kcal
fat; Research Diets, New Brunswick, NJ, USA; # D12331). Animal experiments
were performed in accordance with European guidelines under permission of the
local animal ethics committee of the state of Bavaria or the Regional Council
Tübingen. Whole-body composition (fat and lean tissue mass) was measured using
nuclear magnetic resonance technology (EchoMRI, Houston, TX, USA). For glu-
cose and insulin tolerance test, mice were fasted for 6 h and then challenged with
1.75 g glucose per kg body weight or 0.75 U insulin (Humalog, Eli Lilly, Bad
Homburg, Germany) per kg body weight. Generation of full-length p62 knock-out
mouse lines p62−/− and aP2-cre+;p62loxp/loxp is indicated elsewhere15,16. p62Δ69-
251 mice were generated by Prof. Andre Gessner (University of Regensburg) using a
targeting vector that replaces exons two to four of p62 with a neomycin-resistance
cassette. Ucp1-Cre p62flx/flx mice were generated by pairing p62flx/flx mice with
mice expressing Cre recombinase under control of the Ucp1 promoter.
Indirect calorimetry. Energy expenditure and home-cage activity were assessed
using a climate-controlled combined indirect calorimetric system (TSE System, Bad
Homburg, Germany). After acclimatization for 24 h, levels of O2 and CO2 were
measured every 10 min for 4–5 days. Data for energy expenditure were analyzed
using ANCOVA with body weight as covariate as previously suggested18. For
ANCOVA analysis, energy expenditure raw data were blotted against the indivi-
dual body weight. Every individual data point was then slighted up or down the
group’s own regression line until all data line up at a predefined body weight of 40
g. The result of this ANCOVA correction by body weight was then plotted as a bar
graph as previously suggested18,24.
Cold challenge in wt and p62Δ69-251 mice. Body weight and body composition
was measured at the beginning and end of the study. Mice were acclimatized to
thermoneutrality (30 °C) for 1 day, followed by subsequent measurement of energy
expenditure starting at 30 °C for another day. On Day 3, a non-shivering ther-
mogenesis (NST) test was performed at 30 °C. For the NST test, mice were i.p.
injected with a single bolus of Norepinephrine (Arterenol, Sanofi Aventis, Frank-
furt, Germany; 1 mg kg−1) or saline control. Afterward, the temperature of the
climate chamber was gradually decreased from 30 to 23 °C (2 days), to 10 °C
(1 day), to 5 °C (1 day). Tissues were collected at the end of the study.
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Fig. 6 p62 regulation of ATF2 nuclear target activation. Co-immunoprecipitation (IP) in HEK293T cells transfected with Flag-p62 wt, Flag-p62Δ69-251, or
HA-ATF2, respectively, and stimulated with isoproterenol as indicated. Flag-IP was performed to pulldown p62. Western blot analysis of pulldown (upper
image) and input fraction (lower image) (a). Western blot analysis of ATF2 and p-ATF2 upon p62 overexpression in primary brown adipocytes isolated
from 8-wk-old male p62Δ69-251 mice (b). Nuclear/membrane and cytosolic protein level of ATF2, p-ATF2 (Thr69/71), GAPDH, Histone 3 (H3), and UCP1
in BAT of 12-wk-old male wt and p62Δ69-251 mice upon injection of norepinephrine (1 mg kg−1) for 20min (c). Nuclear/membrane and cytosolic protein
level of p38, p-p38, GAPDH, Histone 3 (H3) as well as total lysates showing UCP1 in BAT of male wt and p62Δ69-251 mice upon injection of norepinephrine
(1 mg kg−1) for 20min (d). Nuclear/membrane and cytosolic protein level of ATF2, p-ATF2 (Thr69/71), GAPDH, Histone 3 (H3) as well as total lysates
showing UCP1 upon 4 h stimulation with 1 µM isoproterenol in immortalized brown adipocytes from 6- to 8-wk-old male p62flx/flx Ucp1-Cre− or p62flx/flx
Ucp1-Cre+ mice (e). Nuclear/membrane and cytosolic protein level of p38, p-p38, ATF2, p-ATF2 (Thr69/71), GAPDH, Histone 3 (H3) as well as total
lysates showing UCP1 upon 4 h stimulation with 10 µM isoproterenol in immortalized brown adipocytes from wt or p62−/− mice (f). Panel (a) represents a
representative example of three independently performed studies, each yielding similar results. Panels (b), (c), (d), and (f) are representative examples of
two independently performed studies, each yielding similar results.
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In vivo PET and MRI studies. Animals were injected i.p. with 11.7 ± 0.3 MBq 18F-
FDG dissolved in saline. Animals were kept awake and allowed to move freely in
their home cages during 18F-FDG uptake for 30 min. Directly after that, the mice
were euthanized with CO2. Static PET acquisitions (10 min) were performed using
a dedicated micro-PET scanner (DPET, Siemens Preclinical Solutions, Knoxville,
USA). The spatial resolution was 1.4 mm (center of field of view), the axial field of
view was 12.7 cm. All PET scans were acquired with an energy window of 350–650
keV and a coincidence timing window of 3.432 ns. All major corrections were
applied to the PET scans (e.g., normalization, decay & deadtime correction), but no
attenuation correction was used as only mice on thin plastic beds were scanned.
PET-images were reconstructed using the three-dimensional ordered-subset-
expectation-maximization (OSEM3D) algorithm with a 128 × 128 matrix and a
final pixel size of 0.79 × 0.79 ×0.80 mm³.
Animals were transferred on-bed to a 7-Tesla small animal MRI scanner
(Clinscan or BioSpec with ParaVision 6.01, Bruker Biospin, Ettlingen, Germany) to
ensure identical mouse positioning on-bed for PET and MRI acquisitions. T2-
weighted anatomical MR-images were acquired using the following 3D-spoiled
turbo spin echo sequence: matrix size: 256 × 256, FOV: 35 × 57 mm2, repetition
time= 800 ms, echo time= 30.8 ms, slice thickness= 0.25 mm, flip angle 90°, echo
train length 16.
PET and MRI data analysis. Inveon Research Workplace (IRW v3.0, Siemens
Preclinical Solutions, Knoxville, USA) was used for data analysis. PET and MRI
data were co-registered for exact, MRI-guided delineation of volumes of interest
(VOI), drawn manually for BAT based on the MR image. PET data were expressed
as standardized uptake value (SUV), calculated as measured activity in BAT
divided by injected activity and body weight.
Infrared thermography. For surface body temperature measurement, 7-d-old
pups were temporarily placed in a 6-well dish for temperature recording via a
thermal imaging camera Optris, OPTPI400 (Ekomess, Heilbronn, Germany).
Bomb calorimetry. For assessment of assimilated energy, food intake and feces
production were assessed over a 5-d period. Feces and food were dessicated in a
drying oven (50 °C) for bomb calorimetric combustion. The assimilated energy was
then calculated by subtracting the energy lost with feces (Eout) from the energy
intake (Ein). Chow control diet was combusted to calculate energy content of the
absorbed food. Bomb calorimetric analysis was performed using a 6300 Oxygen
Bomb Calorimeter (Parr Instrument Technology, IL, USA).
Nuclear extraction. For the protein fractionation, p62Δ69-251 mice aged 17–19 wks
were injected subcutaneously with a single bolus of norepinephrine (Arterenol,
Sanofi Aventis, Frankfurt, Germany; 1 mg kg−1) or saline control and BAT was
collected after 20 min in fractionation buffer (10 mM HEPES pH 7.9, 10 mM KCl,






































































































































































































































































pCRE-Luc + MKK6 + p62 wt
pCRE-Luc + MKK6 + p62Δ69–251
pCRE-Luc + SB203580 (10 μM)
Negative control Jun Fos Atf3 Ucp1 (CRE2) Ucp1 (CRE4) Pgc-1α
Negative control Jun Fos Atf3 Ucp1 (CRE2) Ucp1 (CRE4) Pgc-1αb
a
Fig. 7 Impaired genomic binding of ATF2 in p62Δ69-251 and global p62−/− mice. Chromatin immunoprecipitation (ChIP) in BAT of male wt and p62Δ69-251
mice (a) and p62−/− mice (b) using antibodies specific for ATF2. ChIP-qPCR analysis of Foxl2 (negative control), Jun, Fos, Atf3, Ucp1 (CRE2), Ucp1 (CRE4), and
Pgc-1α (n= 5 mice pooled each genotype, n= 2 technical replicates) (a, b). Luciferase-based CRE reporter assay of HEK293T cells transfected with the pCRE-
Luc reporter, a dominant positive MKK6 (K82A) and p62 wt or p62Δ69-251 (n= 7/8 technical replicates each group) (c). Panel (c) is a representative example
of three independently performed studies, each yielding similar results. Data in (a) and (b) have been analyzed using a two-sided two-tailed t-test, data in
(c) have been analyzed using one-way ANOVA was treatment as co-variant and using Bonferroni multiple comparison between the treatment groups. Data
represent mean ± SEM. *p < 0.05; **p < 0.01; ***p < 0.001. Exact p-values are (c) pCRE-Luc vs. pCRE-Luc+MKK6+ p62 wt p < 0.0001, pCRE-Luc vs. pCRE-Luc
+MKK6+ p62Δ69-251 p > 0.05, pCRE-Luc vs. pCRE-Luc+MKK6+ SB203580 p > 0.05, pCRE-Luc+MKK6+ p62 wt vs. pCRE-Luc+MKK6+ p62Δ69-251 p <
0.0001, pCRE-Luc+MKK6+ p62 wt vs. pCRE-Luc+MKK6+ SB203580 p > 0.0001, pCRE-Luc+MKK6+ p62Δ69-251 vs. pCRE-Luc+MKK6+ SB203580
p=0.0005. Foxl2 forkhead box L2, Fos FBJ osteosarcoma oncogene, Atf3 activating transcription factor 3.
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proteinase and phosphatase inhibitors (Thermo Fisher). After homogenization at
16 Hz for 2 min, samples were centrifuged at 750 × g for 5 min at 4 °C. The
supernatant was collected and centrifuged at 10,000 rpm, 10 min (cytoplasmic
fraction). This process was repeated four times to remove nuclear contamination.
The pellet was washed with fractionation buffer and centrifuged at 750 × g, 5 min to
remove cytoplasmic contamination at least three times. The nuclear/membrane
fraction was dissolved in RIPA buffer.
Cytochrome c oxidase activity measurement. Cox activity of interscapular BAT
was assessed polarographically using a Clark type electrode (RANK Brothers,
Cambridge, USA) and a Powerlab for data processing (ADInstruments, Colorado
Springs, CO, USA). Tissue was weighed and homogenized mechanically in tissue
buffer (100 mM potassium phosphate, 2 mM EDTA, 10 mM glutathione, pH 7.2, at
37 °C) using QIAGEN TissueLyser (Qiagen, Hilden, Germany). Homogenates were
treated with detergent (0.1% n-dodecyl-β-D-maltoside) and subjected to a
temperature-controlled reaction chamber containing 130 μM cytochrome c from
horse heart (Sigma-Aldrich, Munich, Germany) and 18 mM ascorbate in mea-
suring buffer (100 mM potassium phosphate, 5 mM EDTA, pH 7.2, at 37 °C).
Hematoxylin and eosin (H&E) staining. Excised iWAT, rpWAT, eWat, and BAT
samples were fixed in 4% (w/v) neutrally buffered formalin, embedded in paraffin,
cut into 3-μm slices and a hematoxylin and eosin (H&E) staining was performed.
The stained tissue sections were scanned with an AxioScan.Z1 digital slide scanner
(Zeiss, Oberkochen, Germany) equipped with a ×20 magnification objective.
Quantification of adipocytes was performed using ImageJ software.
Isolation of primary adipocytes. Inguinal white adipose tissue was obtained from
6- to 8-wk-old male C57Bl/6J (Janvier Labs, Le Genest-Saint-Isle, France) mice. Fat
pads were minced and digested for 40 min at 37 °C (1 mgml−1 Collagenase IV
(Sigma-Aldrich, Munich, Germany); 3 U/ml Dispase II (Sigma-Aldrich, Munich,
Germany); 0,01 mM CaCl2 in PBS). Cell suspension was filtered through a 100 μm
cell strainer, centrifuged (500 × g for 10 min) and resuspended in growth medium
DMEM/F12 (1:1) plus Glutamax (Thermo Fisher Scientific, Erlangen, Germany),
1% Pen/Strep and 10% FBS after each step. Homogenate was filtered through a 70
μm cell strainer. Primary white adipocytes were plated onto collagen-coated dishes
(Fisher Scientific, Schwerte Germany) and grown to confluence (37 °C, 10% CO2).
At confluence, cells were exposed to an adipogenic cocktail containing dex-
amethasone (1 μM), isobutylmethylxanthine (0.5 mM), rosiglitazone (1 μM) and
insulin (5 μg ml−1) in growth medium. After 48-h induction, cells were maintained
in culture medium containing insulin (5 μg ml−1) and rosiglitazone (1 μM). On
Day 4 of differentiation, cells were cultured in growth medium containing insulin
(5 μg ml−1). To stimulate thermogenesis, cells were treated with 0.5 μM Iso-
proterenol (Sigma-Aldrich, Munich, Germany), dissolved in serum-free growth
medium, for 6 h on Day 6 of adipocyte differentiation.
Primary brown adipocytes were isolated via the same procedure with the
exception that 1 mg/ml Collagenase II (Sigma-Aldrich, Munich, Germany) was
used for digestion. For differentiation of primary brown adipocytes, the induction
cocktail contained dexamethasone (5 μM), isobutylmethylxanthine (0.5 mM),
rosiglitazone (1 μM), indomethacin (125 μM), T3 (1 nM), and insulin (0.5 μg ml−1)
in growth medium. Two days post-induction of differentiation, cells were
maintained in culture medium containing rosiglitazone (1 μM), T3 (1 nM), and
insulin (0.5 μg ml−1). On Day 4 of differentiation, cells were cultured in growth
medium containing T3 (1 nM) and insulin (0.5 μg ml−1).
Oil Red O staining. Cells were fixed with 4% paraformaldehyde (PFA) during
different days of differentiation. Adipocytes were stained with Oil Red O (Sigma-
Aldrich, Munich, Germany) for 10 min and immediately washed with H2O. For
lipid quantification, Oil Red O was retrieved from the cells by 100% isopropanol
and absorbance was measured at 500 nm. Dapi signal was measured to correct for
cell number.
Preparation of RNA and gene expression analysis. Total RNA was prepared
using RNeasy Kit (Qiagen, Hilden, Germany) according to manufacturer’s
instructions. cDNA synthesis was performed with QuantiTect Reverse Transcrip-
tion Kit (Qiagen, Hilden, Germany) according to manufacturer’s instructions.
Gene expression of cell samples (N= 3 per group) was profiled with quantitative
PCR-based (qPCR) techniques using SYBR green or TaqMan Single Probes
(Thermo Fisher Scientific, Erlangen, Germany). The relative expression of the
selected genes was measured using the 7900HT Fast Real-Time PCR System
(Thermo Fisher Scientific, Erlangen, Germany). The relative expression levels of
each gene were normalized to the housekeeping gene peptidylprolyl isomerase B
(Ppib) or Hypoxanthine Phosphoribosyltransferase (Hprt). TaqMan Low Density
Array (Thermo Fisher Scientific, Erlangen, Germany) was performed according to
instructions. The following primers were used: Ucp1 forward 5ʹ-GGCCTCTACGA
CTCAGTCCA-3ʹ, Ucp1 reverse 5ʹ-TAAGCCGGCTGAGATCTTGT-3ʹ, Pgc-1α
forward 5ʹ-AGCCGTGACCACTGACAACGAG-3ʹ, Pgc-1α reverse 5ʹ-GCTGC
ATGGTTCTGAGTGCTAAG-3ʹ, Prdm16 forward 5ʹ-CCGCTGTGATGAGTG
TGATG-3ʹ, Prdm16 reverse 5ʹ-GGACGATCATGTGTTGCTCC-3ʹ, Bmp8b for-
ward 5ʹ-TCCACCAACCACGCCACTAT-3ʹ, Bmp8b reverse 5ʹ-CAGTAGGCAC
ACAGCACACCT-3ʹ, p62/Sqstm1 wild type forward 5ʹ-CCAGTGATGAGGAG
CTGACA-3ʹ, p62/Sqstm1 wild type reverse 5ʹ-CCGTTGCAACCATCACAGAT-3ʹ,
p62/Sqstm1 mutant delta 69–251 forward 5ʹ-CACTACCGCGGCATTGAG-3ʹ, p62/
Sqstm1 mutant delta 69–251 reverse 5ʹ-AGGTTTGCTGACTTCCGAAG-3ʹ. Cidea
forward 5ʹ-AATGGACACCGGGTAGTAAGT-3ʹ, Cidea reverse 5ʹ-CAGCCTGTA
TAGGTCGAAGGT-3ʹ, Dio2 forward 5ʹ-TGCCACCTTCTTGACTTTGC-3ʹ, Dio2
reverse 5ʹ-GGTTCCGGTGCTTCTTAACC-3ʹ, Adiponectin forward 5ʹ-GGTCCTA
AGGGTGAGACAGG-3ʹ, Adiponectin reverse 5ʹ-AGTCCCGGAATGTTGCA
GTA-3ʹ, Fasn forward 5ʹ-AGAGATCCCGAGACGCTTCT-3ʹ, Fasn reverse 5ʹ-GCT
TGGTCCTTTGAAGTCGAAGA-3ʹ, Fabp4 forward 5ʹ-CAGCGTAAATGGGGA
TTTGG-3ʹ, Fabp4 reverse 5ʹ-CCGCCATCTAGGGTTATGAT-3ʹ, Pparg forward
5ʹ-TCGCTGATGCACTGCCTATG-3ʹ, Pparg reverse 5ʹ-GAGAGGTCCACAGAG
CTGATT-3ʹ. The following taqman probes were used: p62Mm01070495_m1, Ucp1
Mm01244861_m1, Pgc-1α Mm01208835_m1, Dio2 Mm00515664_m1, Cidea
Mm00432554_m1, Bmp8b Mm00432115_g1. Hprt Mm01545399_m1, Jun
Mm00495062_s, Fos Mm00487425_m1, JunB Mm04243546_s1, Atf3
Mm00476033_m1, Atm Mm01177457_m1, Xpa Mm00457111_m1, Rad23b
Mm00772280_m1, Msh6 Mm00487761_m1, Nos2 Mm00440502_m1, Hspa5
Mm00517691_m1, Ccna1 Mm01292554_m1, Ccnd1 Mm00432359_m1, Tnf
Mm00443258_m1, Il8 Mm00441263_m1, Il1b Mm00434228_m1, Il6
Mm00446190_m1, Th Mm00447557_m1, Col1a1 Mm00801666_g1, Mmp2
Mm00439498_m1, Sele Mm00441278_m1, Selp Mm01295931_m1, Vcam1
Mm01320970_m1, Ppargc1 Mm01208835_m1, Ucp1 Mm01244861_m1, Zfp516
Mm00813584_m1, Mapk14 Mm01301009_m1, Creb1 Mm00501607_m1, Brca1
Mm00515386_m1, Bcl2L1 Mm00437783_m1, Ddit3 Mm01135937_g1, Adrb2
Mm02524224_s1, Map2k6 Mm00803694_m1, Ep300 Mm00625535_m1, Bcl6
Mm00477633_m1, Nfil3 Mm00600292_s1, Pdgfra Mm00440701_m1, Atf6
Mm01295319_m1, Atf4 Mm00515325_g1, Ulk1 Mm00437238_m1, Atg7
Mm00512209_m1, Atf13 Mm00521135_m1, Map1lc3a Mm00458724_m1.
Bioenergetic analysis. Primary BAT cells were isolated and differentiated for 5 d
on a collagen-coated XF24 well plate. On Day 5, cells were washed with DMEM XF
Assay medium (Seahorse Bioscience, Santa Clara, CA, USA), supplemented with
25 mM glucose, no pyruvate and no fatty-acid free BSA. All port compounds were
dissolved in pure DMEM XF Assay medium without supplements and 10-fold
higher concentrated compounds were loaded into the ports of a XF Assay Car-
tridge. Oxygen consumption rate (OCR) was measured using an extracellular flux
analyzer (XF24, Seahorse Bioscience, Santa Clara, CA, USA). Basal OCR was
recorded for 15 min followed by measurement of OCR after injection of oligomycin
(5 μg ml−1, 15 min), isoproterenol (1 μM, 15 min), 2,4-Dinitrophenol (DNP) (100
μM, 9 min), rotenone (5 μM)/antimycin (2 μM)/2-Deoxyglucose (100 mM) (15
min). For normalization, the cell plate was subsequently co-stained with Dapi and
Nile red and the fluorescence signal was detected to correct for cell number and
differentiation. Proton leak respiration was calculated by subtraction of Rot/AA/
2DG-OCR from Oligomycin-OCR.
Co-immunoprecipation. HEK293FT cells (ATCC, Manassas, VA, USA; #CRL-
3216) or HEK293T cells (ATCC, Manassas, VA, USA; #CRL-1573) were cultured
in 6-well plate and transfected with 1.5 μg Flag-p62 and 1.5 μg HA-ATF2 plasmid
per well by polyethylenimine (linear, MW-25000, Polysciences, Hirschberg, Ger-
many) for 24 h. Isoproterenol (10 μM) was added half an hour before the cells were
collected. The protein lysate of 1500 μg was incubated with anti-Flag-agarose
(Sigma-Aldrich, Munich, Germany) overnight for immunoprecipitation, together
with 50 μg lysate as input to be loaded for western blotting detection of HA (anti-
HA, Cell Signaling Technology) or Flag tag (anti-Flag). Antibodies were obtained
from the following sources: Anti-HA (C29F4) (Cell Signaling, Danvers, MA, USA;
#3724S; dilution: 1:1000), anti-FLAG-M2 (Sigma-Aldrich, St. Louis, MO, USA;
#F1804; dilution: 1:2000), anti-beta-actin (Cell Signaling, Danvers, MA, USA
#4967S; dilution: 1:2000), anti-rabbit (Sigma-Aldrich, St. Louis, MO, USA; #A3687;
dilution: 1:20,000), anti-mouse (Sigma-Aldrich, St. Louis, MO, USA; #A3562;
dilution: 1:20,000).
Western blot analysis. For protein quantification, mice were euthanized by CO2,
tissues were rapidly frozen on dry ice and stored at −80 °C until further analysis.
Fat tissues were lysed in ice-cold RIPA buffer (Sigma-Aldrich, Munich, Germany)
containing protease/phosphatase inhibitor (Thermo Scientific, Rockford, IL, USA),
1 mM PMSF (Carl Roth, Karlsruhe, Germany), and 10 nM Calyculin A (New
England Biolabs, Frankfurt, Germany) using a polytron. Proteins were separated on
Criterion gel (Bio-Rad, Munich, Germany) and transferred onto nitrocellulose
membranes. Membranes were incubated with primary antibody (New England
Biolabs, Frankfurt, Germany) overnight at 4 °C, and HRP-coupled secondary
antibody (Santa Cruz Biotechnology Inc., Delaware, CA, USA) was utilized to
detect protein signal via the LI-COR imaging system or the BioRad Chemidoc
system. The following antibodies were used:, ATF2 (Cell Signaling, Frankfurt,
Germany; #35031; dilution: 1:1000), ATF2 (Santa Cruz Biotechnology, Dallas, TX,
USA; #sc-187; dilution: 1:500), ATF2 (Santa Cruz Biotechnology, Dallas, TX, USA;
#sc-242(F2BR1); dilution 1:70), GAPDH (Santa Cruz Biotechnology, Dallas, TX,
USA; #365062; dilution: 1:10,000), GAPDH (Santa Cruz Biotechnology, Dallas, TX,
USA; #sc-32233; dilution: 1:20,000), H3 (Abcam, Berlin, Germany; #ab1791;
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dilution 1:25,000), p-ATF2 (Cell Signaling, Frankfurt, Germany; #9225; dilution:
1:1000), p-ATF2 (Thermo Fisher Scientific, Waltham, MA, USA; #05891; dilution:
1:2000), p-p38 (Cell Signaling, Frankfurt, Germany; #4511; dilution: 1:800), p-p38
(Cell Signaling, Frankfurt, Germany; #9211; dilution: 1:400), p38 (Cell Signaling,
Frankfurt, Germany; #9212; dilution: 1:1000), p38alpha (Santa Cruz Biotechnology,
Dallas, TX, USA; #sc-728; dilution: 1:500), Ucp1 (Abcam, Berlin, Germany;
#ab23841; dilution: 1:2000), Ucp1 (Abcam; #ab10983; dilution: 1:6000), p-PKC
(Cell Signaling, Frankfurt, Germany; #2060; dilution: 1:2000), ERK1/2 (Cell Sig-
naling, Frankfurt, Germany; #9102; dilution: 1:2000), LC3A/B (Cell Signaling,
Frankfurt, Germany; #4108; dilution: 1:2000), ATG7 (Cell Signaling, Frankfurt,
Germany; #8558; dilution: 1:2000), alpha Tubulin (Santa Cruz Biotechnology,
Dallas, TX, USA; #sc-8035; dilution: 1:1000), p-p44/42 MAPK (ERK1/2) (Cell
Signaling, Frankfurt, Germany; #4511; dilution 1:1000). Images of uncropped blots
are provided in the Source data file.
Chromatin immunoprecipitation (ChIP) and real-time qPCR. ChIP-qPCR of
mouse brown adipose tissue was performed with sonicated nuclear extract pre-
pared from formaldehyde-cross-linked tissue, according to Mir et al.25, using two
different ATF2 antibodies ATF2 (Bethyl Laboratories, Hamburg, Germany; #A301-
649A; dilution: 1:300) or rabbit IgG (Cell Signaling, Frankfurt, Germany, #2729S)
and two different p62 antibodies (Proteintech, Machester, UK; #18420-1AP;
dilution 1:100) and p62 (Abcam, Berlin, Germany; #ab101266; dilution: 1:500).
Immunoprecipitated DNA was decrosslinked, purified and used for quantitative
real-time PCR. Primer sequences used are the following: Foxl2 forward 5ʹ-GCTGG
CAGAATAGCATCCG-3ʹ, Foxl2 reverse 5ʹ-TGATGAAGCACTCGTTGAGGC-3ʹ,
Jun forward 5ʹ-CGCAGCGGAGCATTACCTC-3ʹ, Jun reverse 5ʹ-GCCTGAGCTC
AACACTTATCTG-3ʹ, Fos forward 5ʹ-GCTGAGGCGCCTACTACTCC-3ʹ, Fos
reverse 5ʹ-TCATGGTCGAAGTTTGGGGAAA-3ʹ, Atf3 forward 5ʹ-TTAGCCGAT
TGGCTCCACTG-3ʹ, Atf3 reverse 5ʹ-CGTCAGCCTGGGATTGGTAA-3ʹ, Ucp1
(CRE2) forward 5ʹ-AGTGAAGCTTGCTGTCACTC-3ʹ, Ucp1 (CRE2) reverse 5ʹ-
GTCTGAGGAAAGGGTTGACC-3ʹ, Ucp1 (CRE4) forward 5ʹ-GAGTGACG
CGCGGCTGGG-3ʹ, Ucp1 (CRE4) reverse 5ʹ-GGGCTAGGTAGTGCCAGT-3ʹ,
Pgc-1α forward 5ʹ-ACTATAGGGCACGCGTGGTCGACG-3ʹ, Pgc-1α reverse 5ʹ-
ACACAGAGCACACACTCATGCAGG-3ʹ.
Luciferase assay. ATF2 transcriptional activity was monitored in vitro using a
reporter construct consisting of four tandem copies of the CRE-binding sequence
TGACGTCA linked to luciferase. HEK293T cells (ATCC, Manassas, VA, USA)
were transiently transfected with the following plasmids using Lipofectamine 2000
according to manufacturer’s (Thermo Fisher, Waltham, MA, USA): pCRE-Luc,
pRL-TK, pcDNA3-Flag MKK6(K82A) (Addgene, Watertown, MA, USA; #13519)26,
pcDNA3.1-C-DYK-p62wt, pcDNA3.1-C-DYK-p62Δ69-251, pcDNA3.1. The ATF2
reporter (pCRE-Luc) was a kind gift from Takayuki Akimoto.
Transfection was performed in collagen A-coated 96-well plates using 0.25 μg
plasmid DNA and 0.875 μl Lipofectamine 2000 reagent in a volume of 25 μl
Optimem media. To warrant equal DNA uptake of the cells, the plasmid DNA
concentration was adjusted with an empty vector (pcDNA3.1). CRE-binding
activity reporter assay was performed using the Dual-Glo luciferase assay
(Promega, Madison, WI, USA), which allows normalization to transfection
efficiency by simultaneous measurement of firefly and renilla (pRL-TK)
luminescence. Therefore, the pRL-TK construct was routineously co-transfected to
all samples. Luciferase assay was performed according to protocol and
luminescence signal was measured using a PHERAstar plate reader.
p62 Transfection studies. Primary brown adipocytes isolated from p62−/− mice
were transiently transfected with the following plasmids using Lipfectamine P3000
according to manufacturer’s protocol (Thermo Fisher, Waltham, MA, USA):
pcDNA3.1 and pcDNA3.1-C-DYK-p62wt. Transfection was performed on Day 4
of differentiation in 6-well plates using 4 μg plasmid DNA and 12 μl Lipofectamine
reagent in 250 μl OptiMem medium. Cells were harvested in RIPA buffer for
western blot analysis on Day 6 of differentiation.
Statistics. Statistical analyses were performed using statistical tools in GraphPad
Prism8 (version 8.3.0). Differences between groups were assessed by Student’s two-
sided two-tailed t-test, one-way ANOVA, or two-way ANOVA with time and
genotype as co-variants followed by Bonferroni’s post hoc multiple comparison
testing for individual time points. All results are given as mean ± SEM. P < 0.05 was
considered statistically significant. Differences in energy expenditure were calcu-
lated using ANCOVA with body weight as covariate using SPSS (version 24). For
animal studies, sample sizes were calculated based on a power analysis assuming
that a ≥5 g difference in body weight between genotypes can be assessed with a
power of ≥75% when using a two-sided statistical test under the assumption of a
standard deviation of 3.5 and an alpha level of 0.05.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the findings of this study are available from the corresponding
author upon reasonable request. The source data underlying Figs. 1a–j, 2a–i, 3a–e, 4a, c–j,
5a, b, d, 7a–c, Supplementary Figs. 1b–e, h, i, 2a–f, 3b–d, 4a–f, 5b–f, h–l, 6a–h, 7a–I, 8a, b,
9a, b, 10a, b are provided as a Source data file.
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